Hand sanitizers
This article was originally published in The Rose Sheet
Executive Summary
"Consumers should be alerted to check the alcohol concentration in hand sanitizers because sub-standard products may be marketed to the public," Scott Reynolds, James Quillen Veterans Affairs Medical Center, Mountain Home, Tennessee, et al., conclude in March issue of CDC's Emerging Infectious Diseases. A 40% ethanol product that was obtained from a drugstore and claimed to reduce germs and bacteria by 99.9% was instead found to increase bacteria on hands, authors state. Reynolds et al. tested five hygiene treatments: tap water, 40% ethanol and commercial gels of varying concentrations. Each participant's dominant hand was placed on soy agar plates for five seconds, then treated and reapplied to a fresh plate. Tap water, 40% ethanol and 40% ethanol gel yielded "no significant reductions" in mean bacteria colony forming units, but a 40% gel that was supplemented with ethanol to a final concentration of 62% reduced CFU by 90%, authors find. Survey of 18 retailers found three stores of one discount chain offered a sub-standard product, which suggests that "poorer segments of the population may be more at risk of purchasing inadequate antiseptic gels," they say...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.